menu search

Ligand: nothing exciting stands out

Ligand pharmaceuticals Incorporated generates revenue through licensing technologies, contractual fees,...

September 1, 2023, 11:37 am

Ftc, amgen strike deal to allow $27.8 billion horizon therapeutics acquisition to move forward

The FTC had filed a lawsuit in May seeking to block the acquisition, arguing that the deal would "stifle competition" in the ...

September 1, 2023, 8:49 am

How much pain will lower medicare prices cause for pharma stocks?

Major pharmaceutical companies including Johnson & Johnson NYSE: JNJ, Novartis AG NYSE: NVS, Bristol...

September 1, 2023, 7:01 am

Medivir hosts expert perspectives webcast on the evolving treatment landscape and the unique treatment challenges in hcc

STOCKHOLM , Sept. 1, 2023 /PRNewswire/ -- Medivir AB (NASDAQ Stockholm: MVIR), a pharmaceutical company...

September 1, 2023, 3:20 am

Relief therapeutics to participate in the h.c. wainwright 25th annual global investment conference

GENEVA, SWITZERLAND / ACCESSWIRE / September 1, 2023 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief Therapeutics), a bio...

September 1, 2023, 3:15 am

Supernus to participate in the wells fargo healthcare conference

ROCKVILLE, Md., Aug. 31, 2023 (GLOBE NEWSWIRE) — Supernus pharmaceuticals, Inc. (Nasdaq: SUPN), a bio...

August 31, 2023, 9:30 pm

23andme stock rallies more than 23% after genetics company gets ok to report more cancer risks

Shares of 23andMe Holding Co. ME, -4.35% jumped 23% in the extended session Thursday after the genetics and bio...

August 31, 2023, 5:49 pm

Xenon pharmaceuticals to present at the wells fargo 2023 healthcare conference

VANCOUVER, British Columbia, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Xenon pharmaceuticals Inc. (Nasdaq:XENE)...

August 31, 2023, 4:01 pm

Generic drugmakers start shipping copies of takeda's adhd drug vyvanse

Drugmakers have begun shipping copycat versions of Takeda pharmaceutical's drug Vyvanse, which is expec...

August 31, 2023, 3:49 pm

Knightscope (kscp) stock pops 3% on new 7-robot contract

Shares of security-focused robotics firm Knightscope (NASDAQ: KSCP ) popped higher on Thursday, bolstered by a new contract with a New York-based ...

August 31, 2023, 1:59 pm

Janone to present in person and by video at h.c. wainwright's 25th annual global investment conference

Chief Medical Officer Dr. Amol Soin will discuss innovative approaches to pain management and JanOne's development of non-addicting treatments for pai...

August 31, 2023, 1:30 pm

Abbott's (abt) libre gains momentum amid low testing sales

Banking on the successful execution of Abbott's (ABT) branded generic operating model, EPD is well positioned for sustained growth in many of the grow...

August 31, 2023, 12:02 pm

Mgc pharmaceuticals hails pivot to medical products, legacy sales hit

MGC pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) hailed a "year of great productivity" as it pivot...

August 31, 2023, 11:12 am

J&j (jnj) updates 2023 guidance after final kenvue separation

With the complete separation of the Consumer Health segment, J&J (JNJ) is now a two-sector company focused on the ...

August 31, 2023, 10:32 am

Why is acer therapeutics (acer) stock up 85% today?

Acer Therapeutics (NASDAQ: ACER ) stock is taking off on Thursday after the pharmaceutical company ann...

August 31, 2023, 8:49 am

Mindset pharma to be acquired by otsuka pharmaceutical in all-cash deal

Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) announced that it has agreed to be acquired by Otsuka pharmaceutica...

August 31, 2023, 8:32 am

Third harmonic bio to participate in the morgan stanley global healthcare conference

SAN FRANCISCO, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a biopharmaceutical<...

August 31, 2023, 8:30 am

Filament health enters licensing agreement with reset pharma for botanical psilocybin drug candidate

Filament Health Corp (OTCQB:FLHLF) told investors it has entered into a licensing agreement with Reset pharmac...

August 31, 2023, 8:27 am

Fate therapeutics to present at upcoming september investor conferences

SAN DIEGO, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage b...

August 31, 2023, 8:00 am

Oxford cannabinoid technologies hails defining year as clinical trials remain on track

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) hailed a “defining year” for the progress of its leading drug candidates and ...

August 31, 2023, 2:55 am


Search within

Pages Search Results: